- WPVI – Philadelphia
Woman accused of shooting at passing driver in Chesco
According to investigators, the victim said he was slowly passing by the suspect's Toyota Rav 4 when she allegedly fired one gunshot.
- Yahoo Finance Video
The two ways Amgen's new weight-loss drug can stand out
Pharmaceutical stock Amgen (AMGN) is rising following early positive results from the development of its new GLP-1 weight-loss drug, MariTide. Yahoo Finance Senior Health Reporter Anjalee Khemlani breaks down two ways MariTide could stand out among other obesity drugs, like Novo Nordisk's (NVO) Wegovy and Ozempic and Eli Lilly's (LLY) Zepbound and Mounjaro Khemlani points to Amgen's claim that MariTide could be a monthly injection, giving it a significant leg up against drugs that require more frequent doses, like Ozempic. However, more data is needed before a final conclusion is made, and as phase three trials approach, all eyes are on whether the drug can successfully stand up to the claims. Additionally, pricing remains a major focus in the GLP-1 drug class, which Khemlani stresses will be a key factor in whether Amgen can successfully compete among some of the strongest market leaders. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
- WABC – NY
AccuWeather: Late shower on Saturday
Cloud cover increases on Saturday, with showers showing up later in the day.
